Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

Time for real-world health data to become routine

Real-world data reflect the diversity and lived experiences of individuals and so should be a central pillar of clinical research and care.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amy Abernethy.

Ethics declarations

Competing interests

A.A. is the President, Product Development & Chief Medical Officer of Verily Life Sciences. A.A. reports employment and equity ownership in Verily Life Sciences; membership in the boards of directors for EQRx, Inc. (publicly held company) and Georgiamune LLC (privately held company), and personal investments in One Health and Iterative Scopes.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abernethy, A. Time for real-world health data to become routine. Nat Med 29, 1317 (2023). https://doi.org/10.1038/s41591-023-02337-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02337-0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing